Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC) Meeting Abstract


Authors: Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; Mills, G. B.; Cantley, L.; Winer, E. P.
Abstract Title: Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202775
PROVIDER: wos
Notes: Meeting Abstract: 2510 -- Source: Wos
MSK Authors
  1. David Solit
    431 Solit
Related MSK Work